This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3 WH Giles , JB Croft , KJ Greenland , ES Ford , SJ Kittner . Total homocysteine concentration and the likelihood of nonfatal stroke. Results from the third National Health and Nutrition Examination Survey, 1988–1994. Stroke 1998; 29: 2473–77.
4 EL Mayer , DW Jacobsen , K Robison . Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27; 517–27.
5 P Verhof , MJ Stampfer , JE Buring Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B6, B12 and folate. Am J Epidemiol 1996; 143: 845–59.
6 MM Rees , GM Rodgers . Homocysteinaemia : association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993; 71: 337–59.
7 JB Ubbink . Assay methods for the measurement of total homocysteine in plasma. Semin Thromb Hemost 2006; 26: 233–41.
9 SS Kang , PW Wong , MR Malinow . Hyperhomocysteinaemia and risk factors for occlusive vascular disease. Ann Rev Nutr 1992; 12: 279–98.
11 K Robinson , E Mayer , DW Jacobson . Homocysteine and coronary artery disease. Cleve Clin J Med 1994; 61: 438–50.
12 L Brattstrom , DE Wilcken , J Onrik , L Brudin . Common methylene tetrahydrofolate reductase gene metabolism leads to hyperhomocysteinaemia, but not to vascular disease: result of a meta-analysis. Circulation 1998; 98: 2520–26.
13 B Wilken , F Bamforth Geographical and ethnic variation of the 677 C → T allele of 5, 10 methyltetrahydrofolate reductase MTHFR: finding over 7000 newborns from 16 areas worldwide. J Med Genet 2003; 40: 619–25.
14 P Frost , HJ Bloom , R Milos A candidate genetic risk factor for vascular disease : a common mutation in methylene tetrahydrofolate reductase. Nat Genet 1995; 10: 111–13.
15 F Bruschi , R Daguati , F Parazzini Age, menopausal status and homocysteine levels in women around menopause. Eur J Obstet Gynaecol Reprod Biol 2005; 120: 195–97.
16 A Lindgren , L Brattstrom , B Norving , B Hultberg , A Anderson , BB Johansen . Plasma homocysteine in the acute and convalescent phase after stroke. Stroke 1995; 26: 795–800.
17 DJ Meiklejohn , MA Vickers , R Dijkhuisen , M Greaves . Plasma homocysteine concentration in the acute and convalescent periods of atherothrombotic stroke. Stroke 2001; 32: 57–62.
18 VJ Howard , EG Sides , GC Newman Stability of Plasma Homocysteine in Acute Stroke Patients (SHASP) Study Investigators. Changes in plasma homocysteine in the acute phase after stroke. Stroke 2002; 33: 473–78.
19 G Alfthan , J Pekkanen , M Jauhiainen Relationship of serum homocysteine and lipoprotein concentrations to atherosclerotic disease in a prospective Finnish population-based study. Atherosclerosis 1994; 106: 9–19.
20 P Verhoef , CH Hennekens , MR Malinow A prospective study of plasma homocysteine and risk of ischaemic stroke. Stroke 1994; 25: 1924–30.
21 O Nygard , SE Vollset , H Refsum , I Stensvold Total plasma homocysteine and cardiovascular risk profile : the Hordaland Homocysteine study. JAMA 1995; 274: 1526–33.
22 IJ Perry , H Refsum , RW Morris , SB Ebrahim , PM Cleland , AG Sharper . Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–98.
23 JF Toole , MR Malinow , LE Chamblers Lowering homocysteine in patients with ischaemic stroke to prevent recurrent stroke, myocardial infarction and death: the Vitamin Intervention for Stroke Prevention VISP randomised controlled trial. JAMA 2004; 291: 565–75.
24 ML Bots , LJ Launer , Lindemans Homocysteine and short-term risk of myocardial infarction and stroke in the elderly : the Rotterdam Study. Arch Intern Med 1999; 159: 38–44.
25Homocysteine Studies Collaboration. Homocysteine and risk of ischaemic heart disease and stroke. JAMA 2002; 288: 2015–23.
26 AG Bostom , IH Rosenberg , H Silbershatz , PF Jacques Non-fasting plasma total homocysteine levels and stroke incidence in the elderly person: The Framingham Study. Ann Int Med 1999; 131: 352–55.
27 JW Eikelboom , GJ Hankey , SS Anand , E Lofthouse , N Staples , RI Baker . Association between high homocysteine and ischaemic stroke due to large- and small-artery disease but not other aetiologic subtypes of ischaemic stroke. Stroke 2000; 31: 1069–75.
28 NC-K Tan , N Vanketasubramanian , SM Saw , HTL Tjia . Hyperhomocysteinaemia and risk of ischaemic stroke among young Asian adults. Stroke 2002; 33: 1956–62.
29 IM Van Der Meer , MPM de Maat , AE Hak C reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree. The Rotterdam study. Stroke 2002; 33: 2750–55.
30 LA Harker , SJ Stichter , CR Scott , R Ross . Homocysteinaemia: vascular injury and arterial thrombosis. N Eng J Med 1974; 291: 537–43.
31 LA Harker , R Ross , SJ Stichter , CR Scott . Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731–41.
32 OD Ratnoff . Activation of Hageman factor by L-homocysteine. Science 1968; 162: 1007–9.
33 GM Rodgers , WH Kane . Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 1986; 77: 1909–16.
35 SR Lentz , JE Sadler . Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991; 88: 1906–14.
36 RH Fryer , BD Wilson , DB Eubler , LA Fitzgerald , GM Rodgers . Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993; 13: 1327–33.
37 M Nishinaga , T Ozawa , K Shimade . Homocysteine, a thrombogenic agent, suppresses anticoagulant heparin sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest 1993; 92: 1381–6.
38 JC Tsai , H Wang , MA Perrella Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: 146–53.
39 W Hermann , M Hermann , R Obeid . Hyperhomocysteinaemia: a critical review of old and new aspects. Curr Drug Metab 2007; 8: 17–31.
40The Heart Outcome Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Eng J Med 2006; 354: 1567–77.
41 KH Bonaa , I Njostad , PM Cleland Homocysteine-lowering and cardiovascular events after acute myocardial infarction. N Eng J Med 2006; 354: 1578–88.